RNAi Therapeutics
We are focused on exciting areas of research, learn more.
Latest Vacancies
Latest News
Pfizer plans for first in-house RNAi Rx IND by 2011 as it evaluates all technologies. With two RNAi-based therapies acquired from other companies already in the clinic, Pfizer is now aiming to have an entirely internally developed RNAi drug ready to enter human trials within three years, a senior company official told RNAi News last week.